Benjamin Lightburn, MBA
CEO and Co-Founder, Filament Health
Ben Lightburn is the Chief Executive Officer and a Director of Filament. Mr. Lightburn has 15 years of experience in the natural health and technology sectors. Mr. Lightburn was previously the CEO of Mazza Innovation Ltd. (“Mazza”), which was focused on the commercialization of a phytochemical extraction technology called the PhytoClean Method™. Mr. Lightburn raised over $10 million in angel and venture capital and over $2 million in non-dilutive financing from local and international investors, recorded three successive years of triple-digit revenue growth (with two years of +$1M growth), grew the team from 8 to 28 employees, developed partnerships with leading multinationals such as BASF and Givaudan, and added several patents to the portfolio relating to existing and new technologies. In 2018 Mazza was sold to Sensient Technologies (NYSE:SXT) for $26M. Earlier in his career, Mr. Lightburn was the Business Manager at Radient Technologies. He managed technicians and chemists who produced high value plant extracts for use as active pharmaceutical ingredients. Mr. Lightburn received a Master of Business Administration (MBA) from the Sauder School of Business at UBC and a Bachelor of Science (Honours) in Physics from Queen’s University.